Morphea is an insidious disease with an unpredictable course and wide spectrum of clinical manifestations ranging from skin-limited plaques to linear morphea involving muscle or bone. There can be morbidity from cosmetic disfigurement, functional limb defects, or internal organ involvement. Studies have demonstrated the efficacy of methotrexate or UV-A1 phototherapy for severe disease; however, even after treatment or spontaneous remission, scars and other permanent disease sequelae remain.
Chiu YE. Evaluating the Clinical Utility of Autoantibodies in Morphea. JAMA Dermatol. 2013;149(10):1166. doi:10.1001/jamadermatol.2013.4908
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.